India mulls instituting a maximum retail price cap on medical devices in the wake of price gouging allegations against some of medtech's largest players.
Indian regulators may impose price control measures on such medical devices as stents, catheters and implants in response to allegations of price gouging and bribery, according to a report in the Business Standard.
India's health ministry and department of pharamaceuticals are considering a maximum retail price cap under the National Pharmaceutical Pricing Authority, which monitors the price of 348 medicines deemed essential, the Indian newspaper reported.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tVrt5o
Cap comentari:
Publica un comentari a l'entrada